Rapid Microbiology Testing Market

The rapid microbiology testing market is valued at an estimated USD 5.2 billion in 2024 and is projected to reach USD 8.3 billion by 2029 at a CAGR of 10.1% during the forecast period. In recent times, the rapid microbiology testing market is experiencing an exponential growth due to the rising prevalence of infectious diseases, advancements in technology, and a stronger emphasis on early infectious disease detection.

The key players in rapid microbiology testing market are bioMérieux SA (France), Danaher Corporation (US), Becton, Dickinson and Company (US), Abbott Laboratories (US), Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Sartorius AG (Germany), Bruker (US), QuidelOrtho Corporation (US), Charles River Laboratories (US), Neogen Corporation (US), Don Whitley Scientific Limited (UK), Rapid Micro Biosystems, Inc. (US), Gradientech (Sweden), rqmicro AG (Switzerland),  Colifast AS (Norway), Serosep Limited (Ireland), Solus PerkinElmer (US), BTNX Inc. (Canada), R-Biopharm AG (Germany), Paragon Genomics, Inc. (US), Kypha Inc. (US), Vivione Biosciences (US), Bactest Ltd. (UK), and  CorDx (US).

To know about the assumptions considered for the study download the pdf brochure

In 2023, bioMérieux SA (France) held the leading position in the rapid microbiology testing market.  The company has maintained a strong position in the market through its extensive distribution networks in America, Europe, the Middle East & Africa, and Asia Pacific. bioMérieux also invests heavily in research & development and employs organic growth strategies to strengthen its position in the market. To achieve this, the company focuses on product launches to capture a larger market share. In February 2023, the company received US FDA 510(k) clearance and a Clinical Laboratory Improvement Amendments (CLIA) waiver for its BIOFIRE SPOTFIRE System and BIOFIRE SPOTFIRE Respiratory (R) Panel. The BIOFIRE SPOTFIRE solution enables prompt care for patients with respiratory tract infections, providing results within 15 minutes. With a CLIA waiver, non-laboratory professionals can also use the BIOFIRE SPOTFIRE System and BIOFIRE SPOTFIRE R Panel at the point of care.

In 2023, Becton, Dickinson and Company (US) commanded a substantial market share within the rapid microbiology testing market. Its success in this market can be attributed to its strong global sales and distribution network, which enables it to effectively market its products in various countries. Additionally, BD has increased its focus on research & development (R&D) activities to develop more unique and better products than its competitors. Its investments in R&D and capital allocation strategies help fuel its future growth and ability to remain competitive in the market. Furthermore, the company’s strategies, which involve product launches and regulatory approvals, aim to further solidify its position in the rapid microbiology testing market.

In 2023, Danaher Corporation (US) held a prominent position in the rapid microbiology testing market. The company has established a strong position in the rapid microbiology testing market. To maintain this position, it uses both organic and inorganic growth strategies.

Related Reports:

Rapid Microbiology Testing Market by Product (Instruments (Automated Identification System, PCR, Mass Spectrometer) Reagent, Kits), Method (Growth, Nucleic Acid, Viability), Application (Clinical Diagnosis, Industrial, Research) - Global Forecast to 2029

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]